We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Marker for Illness and Disease

By HospiMedica staff writers
Posted on 12 Aug 2004
A condition called metabolic syndrome has been found to be closely linked to breast and prostate cancer as well as diabetes, cardiovascular disease, chronic liver disease, and sleep apnea. More...


Diagnosing the condition so that treatment could begin would greatly help to reduce the incidence of illness and disease, since the condition affects more than 25% of all people in the United States. Diagnosis is fairly simple, since those people at risk will have three of the following traits: waist measurement of 40 inches or more among men and 35 inches or more among women, blood triglyceride levels of 150 or greater, blood pressure of 130/83 or higher, and fasting blood sugar of 100 or more. The incidence of metabolic syndrome appears to be higher among people of lower socioeconomic status. Treatment consists mainly of lifestyle changes, such as a vigorous physical fitness program and good nutrition, according to the authors.

The incidence of heart risk associated with metabolic syndrome could be reduced by as much as 10%, and the incidence of diabetes could be reduced by as much as 35%, according to the study conducted by Earl S. Ford, M.D., MPH, of the (U.S.) National Center for Chronic Disease Prevention and Control (Atlanta, GA, USA).

A second study was conducted by Gerald Reaven, M.D., of Stanford University (Palo Alto, CA, USA), who was the first to identify metabolic syndrome. According to Dr. Reaven, the condition also leads to hypertension. His report concludes that a person who is more physically fit will produce appropriate levels of insulin and be less likely to develop metabolic syndrome.

Both studies were presented at the annual meeting of the American Association of Clinical Chemistry in Los Angeles (CA, USA) in July 2004.




Related Links:
National Center for Chronic Disease
Stanford U.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.